<DOC>
	<DOCNO>NCT00523679</DOCNO>
	<brief_summary>The purpose study investigate extent Symbicort use patient prescribed Symbicort maintenance reliever therapy .</brief_summary>
	<brief_title>Symbicort SMART ( Symbicort Maintenance And Reliever Therapy )</brief_title>
	<detailed_description />
	<mesh_term>Budesonide , Formoterol Fumarate Drug Combination</mesh_term>
	<criteria>Asthma patient prescribe Symbicort maintenance reliever therapy , accord label , inclusion program . Since programme intend describe Symbicort use routine clinical practice prescribe Symbicort maintenance reliever therapy , programme specific exclusion criterion , : involvement plan conduct programme ( applies AstraZeneca staff staff investigational site )</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Symbicort</keyword>
	<keyword>SMART</keyword>
	<keyword>inhaler</keyword>
	<keyword>compliance</keyword>
	<keyword>Naturalistic</keyword>
	<keyword>Observational</keyword>
</DOC>